We at Group Health Research Institute (GHRI) felt unsure in early 2013 how sequestration and threats of government shutdown might harm our research, which is mostly federally funded. But we ended the year with confidence and hope.
Group Health Research Institute Scientific Highlights—January 2014
Dr. Whiteside selected for Zero Suicide Advisory Board. Dr. Larson participates in G8 Dementia Summit. Patient-centered research: Dr. Wernli walks the talk. GHRI welcomes Dr. Chien as affiliate investigator
Few health conditions are as common and confounding as back pain, the second leading cause of all doctor visits.
Last month brought good news for those interested in preventing or delaying dementia—which is predicted to triple between now and the year 2050, affecting 115 billion people worldwide.
Research teams at Group Health Research Institute have been approved for funding awards by the Patient-Centered Outcomes Research Institute (PCORI) to study opioid therapy and asthma—and to help expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Virulent, drug-resistant forms of Escherichia coli that have recently spread around the world emerged from a single strain of the bacteria—not many different strains, as has been widely supposed, according to a new study in mBio, the flagship journal of the American Society for Microbiology. The strain causes millions of urinary, kidney, and bloodstream infections a year and has a far greater clinical and economic impact than any other strain of bacteria, including the so-called MRSA (methicillin-resistant Staphylococcus aureus) superbug.”
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.